U.S. review of Biogen Alzheimer's drug could have been handled better -FDA chief
By Carl O'Donnell and Trisha RoyJuly 14 (Reuters) - The U.S. Food and Drug Administration could potentially have done more to avoid the current ...
By Carl O'Donnell and Trisha RoyJuly 14 (Reuters) - The U.S. Food and Drug Administration could potentially have done more to avoid the current ...